Phase 3 trial data confirm efficacy and safety profile of R21/Matrix-M malaria vaccine in African… EP News Bureau Feb 2, 2024 Investigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78 per…
Wockhardt completes Phase 3 pneumonia study of macrolide antibiotic Nafithromycin WCK 4873 EP News Bureau Dec 11, 2023 The results of the study showed that an ultrashort course of three-day treatment with Nafithromycin is as effective as seven-day…
Lilly’s bamlanivimab plus etesevimab cut death, hospitalisations for early COVID-19 in Phase… EP News Bureau Mar 11, 2021 Results support use of bamlanivimab 700 mg and etesevimab 1400 mg, the dose authorised in the US and several other countries
Merck’s Keytruda shows mixed results in phase 3 trial for small cell lung cancer Press Trust of India Jan 7, 2020 While the blockbuster drug showed improvement in overall survival for patients treated with Keytruda in combination with…